Delapril

This classification denotes an ace inhibitor with the molecular formula C26H32N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W77UAL9THI, chemically known as glycine, n-(2,3-dihydro-1h-inden-2-yl)-n-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-, (s)- but generally known as delapril, which bears US NIH Compound Identifier 5362116. European Medicines Agency schedules Delapril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06948MIG. The term DELAPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). World Health Organization schedules delapril in its Anatomical Therapeutic Chemical (ATC) Classification. DELAPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule delapril under HS 29242995 and SITC 51479. As of Q4 2014, DELAPRIL remains the US FDA Preferred Term for this commodity. Delapril bears US NLM identifiers UMLS ID C0057301 and NCI Concept Code C75022. SMILES: O=C(N(C1Cc2c(C1)cccc2)CC(=O)O)C(NC(CCc1ccccc1)C(=O)OCC)C.